Very late stage RCT with 214 patients, mean SpO2
65%, 162 on mechanical ventilation, showing no significant difference in mortality.
Patients not intubated at baseline show greater improvement, HR 0.43 [0.09-2.03].
Table 4 shows different results to the abstract - table 4 adjusted HR 0.80 [0.51-1.23], abstract HR 0.88 [0.51-1.53]. There was no significant difference in severe adverse events.
Hernandez-Cardenas et al., 5 Feb 2021, Randomized Controlled Trial, Mexico, preprint, 6 authors, average treatment delay 7.4 days.